Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jul-24 6:00 PM View:  | Fate Therapeutics Inc (FATE) | 29-Jul-24 | Grant | 200,000 | -- | -- | 140% 142.36K to 342.36K | |
| 10-Jan-24 4:30 PM View: | Fate Therapeutics Inc (FATE) | 09-Jan-24 | Sale | 10,874 | $4.37 | $47,519.40 | (7%) 153.24K to 142.36K | |
| 13-Nov-23 4:01 PM View: | Fate Therapeutics Inc (FATE) | 09-Nov-23 | Sale (Planned) | 24,363 | $2.40 | $58,471.20 | (14%) 177.6K to 153.24K | |
| 11-Jan-23 4:08 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-23 | Sale | 11,553 | $5.24 | $60,537.70 | (6%) 189.15K to 177.6K | |
| 02-Jun-22 4:04 PM View: | Fate Therapeutics Inc (FATE) | 01-Jun-22 | Option Exercise | 25,000 | $6.55 | $163,750.00 | 13% 189.15K to 214.15K | |
| 02-Jun-22 4:04 PM View: | Fate Therapeutics Inc (FATE) | 01-Jun-22 | Planned Option Sale | 25,000 | $22.96 | $574,000.00 | (12%) 214.15K to 189.15K | |
| 04-Apr-22 5:01 PM View: | Fate Therapeutics Inc (FATE) | 01-Apr-22 | Option Exercise | 25,000 | $5.22 | $130,520.00 | 13% 189.15K to 214.15K | |
| 04-Apr-22 5:01 PM View: | Fate Therapeutics Inc (FATE) | 01-Apr-22 | Planned Option Sale | 25,000 | $38.85 | $971,250.00 | (12%) 214.15K to 189.15K | |
| 27-Jan-22 4:06 PM View: | Fate Therapeutics Inc (FATE) | 25-Jan-22 | Grant | 33,302 | -- | -- | 21% 155.85K to 189.15K | |
| 13-Jan-22 4:08 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-22 | Market Sale | 5,419 | $48.53 | $262,975.00 | (3%) 161.27K to 155.85K | (2%) |
| 12-Jan-22 4:06 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-22 | Market Sale | 7,738 | $46.43 | $359,313.00 | (5%) 169.01K to 161.27K | (6%) |
| 04-Jan-22 4:03 PM View: | Fate Therapeutics Inc (FATE) | 03-Jan-22 | Option Exercise | 50,000 | $6.55 | $327,500.00 | 30% 169.01K to 219.01K | |
| 04-Jan-22 4:03 PM View: | Fate Therapeutics Inc (FATE) | 03-Jan-22 | Market Option Sale (Planned) | 50,000 | $59.34 | $2,966,850.00 | (23%) 219.01K to 169.01K | |
| 22-Nov-21 5:43 PM View: | Fate Therapeutics Inc (FATE) | 19-Nov-21 | Grant | 60,958 | -- | -- | 56% 108.05K to 169.01K | |
| 04-Oct-21 4:12 PM View: | Fate Therapeutics Inc (FATE) | 01-Oct-21 | Option Exercise | 50,000 | $6.55 | $327,500.00 | 46% 108.05K to 158.05K | |
| 04-Oct-21 4:12 PM View: | Fate Therapeutics Inc (FATE) | 01-Oct-21 | Market Option Sale (Planned) | 50,000 | $58.83 | $2,941,460.00 | (32%) 158.05K to 108.05K | |
| 02-Apr-21 6:03 PM View: | Fate Therapeutics Inc (FATE) | 01-Apr-21 | Option Exercise | 30,000 | $3.21 | $96,199.50 | 28% 108.05K to 138.05K | |
| 02-Apr-21 6:03 PM View: | Fate Therapeutics Inc (FATE) | 01-Apr-21 | Market Option Sale (Planned) | 30,000 | $83.81 | $2,514,330.00 | (22%) 138.05K to 108.05K | |
| 22-Jan-21 6:21 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-21 | Grant | 18,013 | -- | -- | 20% 90.03K to 108.05K | |
| 21-Jan-21 7:08 PM View: | Fate Therapeutics Inc (FATE) | 19-Jan-21 | Option Exercise | 35,000 | $2.90 | $101,500.00 | 39% 90.03K to 125.03K | |
| 21-Jan-21 7:08 PM View: | Fate Therapeutics Inc (FATE) | 19-Jan-21 | Market Option Sale (Planned) | 35,000 | $114.76 | $4,016,640.00 | (28%) 125.03K to 90.03K | |
| 12-Jan-21 8:39 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-21 | Market Sale | 3,254 | $110.81 | $360,587.00 | (3%) 93.29K to 90.03K | (1%) |
| 12-Jan-21 8:39 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-21 | Market Sale | 6,229 | $117.10 | $729,434.00 | (6%) 99.52K to 93.29K | 4% |
| 06-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 05-Nov-20 | Option Exercise | 19,282 | $2.82 | $54,339.90 | 19% 99.52K to 118.8K | |
| 06-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 05-Nov-20 | Market Option Sale (Planned) | 19,282 | $50.63 | $976,252.00 | (16%) 118.8K to 99.52K | (99%) |
| 06-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 04-Nov-20 | Option Exercise | 51,519 | $2.73 | $140,647.00 | 52% 99.52K to 151.04K | |
| 06-Nov-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 04-Nov-20 | Market Option Sale (Planned) | 51,519 | $50.41 | $2,597,140.00 | (34%) 151.04K to 99.52K | (100%) |
| 20-Oct-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 16-Oct-20 | Option Exercise | 29,199 | $2.73 | $79,713.30 | 29% 99.52K to 128.72K | |
| 20-Oct-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 16-Oct-20 | Market Option Sale (Planned) | 29,199 | $50.25 | $1,467,210.00 | (23%) 128.72K to 99.52K | (101%) |
| 02-Oct-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 01-Oct-20 | Option Exercise | 35,000 | $2.73 | $95,550.00 | 35% 99.52K to 134.52K | |
| 02-Oct-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 01-Oct-20 | Market Option Sale (Planned) | 35,000 | $40.74 | $1,426,070.00 | (26%) 134.52K to 99.52K | (147%) |
| 10-Jan-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-20 | Grant | 25,000 | -- | -- | 31% 80.22K to 105.22K | |
| 10-Jan-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-20 | Market Sale | 5,700 | $20.72 | $118,085.00 | (5%) 105.22K to 99.52K | (387%) |
| 16-Oct-19 4:05 PM View: | Fate Therapeutics Inc (FATE) | 15-Oct-19 | Market Sale | 10,200 | $14.24 | $145,292.00 | (11%) 90.42K to 80.22K | (607%) |
| 05-Mar-19 9:00 AM View: | Fate Therapeutics Inc (FATE) | 01-Mar-19 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 28% 90.42K to 115.42K | |
| 05-Mar-19 9:00 AM View: | Fate Therapeutics Inc (FATE) | 01-Mar-19 | Market Option Sale (Planned) | 25,000 | $16.15 | $403,698.00 | (22%) 115.42K to 90.42K | (524%) |
| 27-Feb-19 4:01 PM View: | Fate Therapeutics Inc (FATE) | 25-Feb-19 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 28% 90.42K to 115.42K | |
| 27-Feb-19 4:01 PM View: | Fate Therapeutics Inc (FATE) | 25-Feb-19 | Market Option Sale (Planned) | 25,000 | $16.07 | $401,820.00 | (22%) 115.42K to 90.42K | (527%) |
| 09-Jan-19 4:03 PM View: | Fate Therapeutics Inc (FATE) | 07-Jan-19 | Grant | 45,000 | -- | -- | 99% 45.42K to 90.42K | |
| 09-Jan-19 4:03 PM View: | Fate Therapeutics Inc (FATE) | 07-Jan-19 | Option Exercise | 25,000 | $2.27 | $56,673.20 | 28% 90.42K to 115.42K | |
| 09-Jan-19 4:03 PM View: | Fate Therapeutics Inc (FATE) | 07-Jan-19 | Market Option Sale (Planned) | 25,000 | $16.00 | $400,000.00 | (22%) 115.42K to 90.42K | (529%) |
| 17-Oct-17 4:04 PM View: | Fate Therapeutics Inc (FATE) | 16-Oct-17 | Market Sale | 500 | $4.10 | $2,050.00 | (1%) 45.92K to 45.42K | (2355%) |
| 17-Oct-17 4:04 PM View: | Fate Therapeutics Inc (FATE) | 13-Oct-17 | Market Sale | 7,591 | $3.83 | $29,073.50 | (14%) 53.51K to 45.92K | (2528%) |
| 12-Jan-16 5:33 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-16 | Grant | 6,633 | -- | -- | 14% 46.88K to 53.51K | |
| 16-Oct-15 5:32 PM View: | Fate Therapeutics Inc (FATE) | 15-Oct-15 | Grant | 40,000 | -- | -- | 582% 6.88K to 46.88K |